|

Understanding of Psychotic Disorders in Children With 22q11.2DS

RECRUITINGN/ASponsored by Hôpital le Vinatier
Actively Recruiting
PhaseN/A
SponsorHôpital le Vinatier
Started2020-11-13
Est. completion2026-06-30
Eligibility
Age4 Years – 13 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04639388

Summary

The study PremiCeS22 will investigate the prodromal signals at the onset of psychotic disorders of children with 22q11.2 deletion syndrome

Eligibility

Age: 4 Years – 13 YearsHealthy volunteers accepted
Inclusion Criteria:

* Diagnosis of 22q11.2 deletion syndrome or no developmental disease
* Aged from 4 to 13 years old
* French language

Exclusion Criteria:

* Diagnosis of intellectual deficiency according to DSM 5 criteria
* Drug prescribed for somatic condition that could influence cerebral functioning

Conditions2

22q11.2 Deletion SyndromeHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.